Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
517K
-
Shares change
-
+30.8K
-
Total reported value, excl. options
-
$1.65M
-
Value change
-
+$97.9K
-
Number of buys
-
11
-
Number of sells
-
-3
-
Price
-
$3.18
Significant Holders of Lipocine Inc. - COM NEW (LPCN) as of Q1 2025
19 filings reported holding LPCN - Lipocine Inc. - COM NEW as of Q1 2025.
Lipocine Inc. - COM NEW (LPCN) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 517K shares
.
Largest 10 shareholders include VANGUARD GROUP INC (226K shares), BlackRock, Inc. (89.3K shares), GEODE CAPITAL MANAGEMENT, LLC (58.8K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (39K shares), RENAISSANCE TECHNOLOGIES LLC (37.5K shares), DIMENSIONAL FUND ADVISORS LP (24.9K shares), STATE STREET CORP (18.6K shares), NORTHERN TRUST CORP (13.2K shares), BANK OF AMERICA CORP /DE/ (2.58K shares), and MORGAN STANLEY (2.58K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.